GCV Symposium
Skip Content

21 April 2017

Boston Scientific helps pump $23m into Neurotronik

Boston Scientific has led a $23.1m series B round for Neurotronik, a medical device devloper focusing on patients suffering from heart failure.

Author: Thierry Heles, Reporter

Ireland-based medical device developer Neurotronik has closed a $23.1m series B round led by medical equipment producer Boston Scientific, with the funding to be provided in tranches in line with milestones.